cancer genetic Downloads
-
Chemoscale - Model 360 - Chemo - Resistance Profiling Technology for Circulating Tumor Associated Cells - Brochure
Chemo-scale is an advanced non-invasive test which provides therapeutically relevant information and is based on a safe, simple, and quick blood draw. Chemo-scale™ investigates in vitro chemo-resistance in Circulating Tumor Associated Cells (CTACs) isolated from the blood sample. CTACs include cancer cells that escape from the tumor and enter the bloodstream (circulating tumor cells, CTCs) ...
-
Cancertrack - Model 360 - Cancer Treatments Technology - Brochure
Cancertrack is an advanced non-invasive blood test which provides real time intel on the status of a malignancy from a safe, simple and quick blood draw. Cancertrack profiles molecular features in circulating tumor DNA and circulating tumor RNA and also evaluates ‘Circulating Tumor Cells’ (CTCs). ...
-
Pinaka - Model 360 - Theranostic Profiling Technology for Circulating Tumor Cells - Brochure
Pinaka™ is an advanced non-invasive blood test which provides therapeutically relevant information via a safe, simple and quick blood draw. Pinaka™ evaluates blood sample to detect ‘Circulating Tumor Cells’ (CTCs), which are cancer cells that escape from the tumor and enter the blood stream. Pinaka™ enriches these CTCs from the blood sample and confirms their ...
-
Exacta - Model 360 - Advanced Cancer Profiling Technology - Brochure
Exacta™ is an intensive and in-depth multi-analyte tumor profiling. It analyses millions of data points at the molecular and functional levels to reveal threats and vulnerabilities which enable optimal identification of targets for precision treatment selection. ...
-
Celldx - Model 360 - Advanced Tumor Profiling Technology for Personalized Targeted Anti-cancer Treatments - Brochure
CellDx is an intensive and in-depth tumor molecular profiling. It analyses millions of data points at the molecular level to reveal threats and vulnerabilities which enable optimal identification of targets for precision treatment selection. ...
-
Model RUO - FP195 15q22/6q21 - Gene Abnormalities Probe Detection Kit - Brochure
Chromosome 6q amplifications encompassing 6q21-22 have been observed in MM including the same region as in CLL. Amplification including band 15q22 has been reported in MM. The 15q22 specific FISH probe is optimized to detect copy numbers at 15q22. The 6q21 specific DNA region is optimized to detect copy numbers at 6q21 (Cremer et al, 2005, Genes Chrom Cancer, 44; 194-203). ...
-
Model IVD - FP195 15q22/6q21 - Gene Abnormalities Probe Detection Kit - Brochure
Chromosome 6q amplifications encompassing 6q21-22 have been observed in MM including the same region as in CLL. Amplification including band 15q22 has been reported in MM. The 15q22 specific FISH probe is optimized to detect copy numbers at 15q22. The 6q21 specific DNA region is optimized to detect copy numbers at 6q21 (Cremer et al, 2005, Genes Chrom Cancer, 44; 194-203). ...
-
Gene Panel Brochure
Targeted panel enriched for clinically relevant genes and most commonly mutated cancer driver genes with additional genes of emerging clinical significance focused on immediately actionable mutations. ...
By Tempus
-
Explore Cancer-related Mutations with NGS
Further mutations may occur in the progeny of the cancer cell, leading to the development of tumour cell invasion and metastasis. The application of NGS provides a high-resolution and global view of the cancer genome in a high throughput manner, revealing several novel cancer-related genes and pathways. ...
By CD Genomics
-
Why Cancer Panels Stand Out for Cancer Research
CD Genomics is an innovative sequencing and genotyping company. Our cancer panels are designed to address the practical needs of cancer-related studies. These panels are featured an innovative background cleaning technique that allows plenty of amplicons to be multiplexed in a single reaction pool, allowing a large number of cancer-related genes to be detected in a single assay. ...
By CD Genomics
-
Cancer Diagnostics Brochure
Identify clinically significant mutations in cancer-associated genes to optimize patient-specific ...
-
The Reasons for Choosing Our Cancer Panels
CD Genomics's cancer panels are predesigned panels for targeted sequencing of genes and mutations associated with multiple cancer diseases. CD Genomics utilizes targeted NGS sequencing technology to provide more efficient and accurate targeting of specific genes or mutations, and even to detect low-frequency variations in cancer-associated genes. ...
By CD Genomics
-
EDI - Human Fetuin-A ELISA Kit - Brochure
This ELISA (enzyme-linked immunosorbent assay) kit is intended for the quantitative determination of human Fetuin-A, also known as alpha-2-HS glycoprotein (AHSG), in serum, plasma, cell culture supernatant, tissue extraction and urine. The measurement of Fetuin-A in serum or plasma aids in the diagnosis of some cancers and genetically inherited deficiencies of this serum protein. This Fetuin-A ...
-
Tempus xG - Brochure
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others (renal/urinary tract, gastric, melanoma, thyroid, endocrine, sarcomas, central nervous system, ...
By Tempus
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you